ArticleJournal of managed care & specialty pharmacy2024

Outcomes of the use of infliximab biosimilars in rheumatology and gastroenterology clinics.

Sarah Steedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.